Last CR was @ 48c/share on 23/10/20 and prior to that, was 25/11/19. Both CRs to sophisticated investors, instos. The share price is now around 89c.
I can understand that retail shareholders got diluted as they could not participate in those CRs but the share price has doubled since as the business progressed. Perhaps, retail shareholders need a Share Purchase Plan(SPP) at next CR?
That Lab. generates about $3m p.a. which offsets a lot of the cash burn and hence, reduces the need for more CRs.
PIQ is a good biotech for long termers to hold in their portfolio, IMO.
Last CR was @ 48c/share on 23/10/20 and prior to that, was...
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.010(1.04%) |
Mkt cap ! $124.3M | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 98.0¢ | 95.0¢ | $146.0K | 151.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 39803 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 36500 | 1 |
View Market Depth
| Last trade - 15.59pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
95.0¢ |
Change
-0.010 ( 1.55 %) |
||||
| Open | High | Low | Volume | ||
| 96.5¢ | 98.0¢ | 95.0¢ | 18716 | ||
| Last updated 15.12pm 06/06/2024 ? | |||||
| PIQ (ASX) Chart |